Prescription drug · NDA
Lotensin HCT NDC 30698-454
benazepril hydrochloride and hydrochlorothiazide · Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 25 mg/1 · Tablet · Oral · Validus Pharmaceuticals LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 30698-454-01 | 3069804540130698045401 | 100 TABLET in 1 BOTTLE (30698-454-01)Marketed from May 30, 1992 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lotensin HCT
- Generic name (nonproprietary)
- benazepril hydrochloride and hydrochlorothiazide
- Active ingredients
- Benazepril hydrochloride — 20 mg/1Hydrochlorothiazide — 25 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Validus Pharmaceuticals LLCNDC labeler code 30698
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020033
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin-converting Enzyme Inhibitors (Mechanism)Decreased Blood Pressure (Physiologic effect)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
- Identifiers
- Product ID 30698-454_4b9222f7-7b31-4781-e063-6394a90ab188SPL ID 4b9222f7-7b31-4781-e063-6394a90ab188SPL set ID 94c4536f-e28e-48b1-8336-b3939917e99dRxCUI 898362, 898366, 898367, 898371, 898372, 898376UNII 0J48LPH2TH, N1SN99T69TUPC 0330698452011, 0330698454015, 0330698453018
- Pharmacologic class
- Angiotensin Converting Enzyme Inhibitor; Thiazide Diuretic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N430698045401followed by a unit qualifier and the quantityPackage 30698-0454-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Lotensin HCT USP is indicated for the treatment of hypertension. This fixed combination drug is not indicated for the initial therapy of hypertension ( see DOSAGE AND ADMINISTRATION ).
Excerpt only. Read the full label for complete information.
About NDC 30698-454
- What is NDC 30698-454?
- 30698-454 is the product NDC for Lotensin HCT, Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 25 mg/1 tablet, listed with the FDA by Validus Pharmaceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lotensin HCT (Benazepril hydrochloride and hydrochlorothiazide).
- What is the active ingredient?
- Benazepril hydrochloride, Hydrochlorothiazide.
- Who is the labeler?
- Validus Pharmaceuticals LLC, NDC labeler code 30698. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lotensin HCT?
- 2 other product NDCs are listed under this name. See all Lotensin HCT NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Lotensin HCT products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Lotensin HCTbenazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 10 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Validus Pharmaceuticals LLC | 30698-452 | 30698-0452-01 |
| Lotensin HCTbenazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Validus Pharmaceuticals LLC | 30698-453 | 30698-0453-01 |
Other NDCs under NDA 020033
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 25 mg/1 | TabletOral | Padagis US LLC | 0574-0228 |
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Padagis US LLC | 0574-0229 |
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Bryant Ranch Prepack | 72162-2328 |
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 10 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Advagen Pharma Ltd | 72888-220 |
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Advagen Pharma Ltd | 72888-221 |
| benazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 25 mg/1 | TabletOral | Advagen Pharma Ltd | 72888-222 |
| Lotensin HCTbenazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 10 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Validus Pharmaceuticals LLC | 30698-452 |
| Lotensin HCTbenazepril hydrochloride and hydrochlorothiazide | Benazepril hydrochloride 20 mg/1; Hydrochlorothiazide 12.5 mg/1 | TabletOral | Validus Pharmaceuticals LLC | 30698-453 |